| Primary |
| Parkinson's Disease |
62.4% |
| Restless Legs Syndrome |
10.2% |
| Hypertension |
8.6% |
| Drug Use For Unknown Indication |
7.0% |
| Depression |
1.9% |
| Prophylaxis |
1.0% |
| Osteoporosis |
1.0% |
| Pain |
0.9% |
| Diabetes Mellitus |
0.8% |
| Myocardial Ischaemia |
0.8% |
| Renal Failure |
0.7% |
| Parkinsonism |
0.7% |
| Anxiety |
0.6% |
| Hypercholesterolaemia |
0.6% |
| Metabolic Disorder |
0.5% |
| Bipolar Disorder |
0.5% |
| Hallucination |
0.5% |
| Blood Cholesterol Increased |
0.5% |
| Cardiac Disorder |
0.4% |
| Thrombosis Prophylaxis |
0.4% |
|
| Tremor |
16.8% |
| Pharmaceutical Product Complaint |
15.4% |
| Parkinson's Disease |
7.1% |
| Drug Ineffective |
6.0% |
| Application Site Reaction |
5.6% |
| Hallucination |
5.1% |
| Somnolence |
5.1% |
| Death |
4.6% |
| Wrong Technique In Drug Usage Process |
4.1% |
| Vomiting |
4.0% |
| Nausea |
3.5% |
| Off Label Use |
3.3% |
| Product Quality Issue |
3.0% |
| Rash |
3.0% |
| Unevaluable Event |
2.9% |
| Application Site Rash |
2.4% |
| Insomnia |
2.1% |
| Skin Reaction |
2.1% |
| Weight Decreased |
2.1% |
| Pneumonia |
1.9% |
|
| Secondary |
| Parkinson's Disease |
50.8% |
| Hypertension |
16.1% |
| Restless Legs Syndrome |
7.4% |
| Renal Failure |
4.3% |
| Depression |
2.5% |
| Prophylaxis |
2.3% |
| Osteoporosis |
2.1% |
| Myocardial Ischaemia |
1.7% |
| Diabetes Mellitus |
1.6% |
| Pain |
1.6% |
| Sleep Disorder |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Metabolic Disorder |
1.1% |
| Hallucination |
1.1% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Hypercholesterolaemia |
0.9% |
| Thrombosis Prophylaxis |
0.9% |
| Multiple Myeloma |
0.8% |
| Cognitive Disorder |
0.7% |
| Coronary Artery Disease |
0.7% |
|
| Parkinson's Disease |
13.5% |
| Atrial Fibrillation |
9.4% |
| General Physical Health Deterioration |
9.4% |
| Inguinal Hernia |
5.6% |
| Death |
5.3% |
| Renal Failure Acute |
4.9% |
| Urinary Tract Infection |
4.9% |
| Brachial Plexus Injury |
4.5% |
| Diarrhoea |
4.5% |
| Gait Disturbance |
4.5% |
| Hallucination |
4.1% |
| Cardiac Failure |
3.8% |
| Brachial Plexopathy |
3.4% |
| Dystonia |
3.4% |
| Renal Failure |
3.4% |
| Tremor |
3.4% |
| Vision Blurred |
3.4% |
| Breast Cancer |
3.0% |
| Sopor |
3.0% |
| Application Site Rash |
2.6% |
|
| Concomitant |
| Parkinson's Disease |
41.1% |
| Product Used For Unknown Indication |
18.1% |
| Restless Legs Syndrome |
7.0% |
| Hypertension |
3.7% |
| Depression |
3.3% |
| Dementia Alzheimer's Type |
3.0% |
| Insomnia |
3.0% |
| Prostatomegaly |
2.6% |
| Type 2 Diabetes Mellitus |
2.2% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Anxiety |
1.5% |
| Arthralgia |
1.5% |
| Blood Cholesterol Increased |
1.5% |
| Blood Pressure |
1.5% |
| Dressler's Syndrome |
1.5% |
| Eating Disorder |
1.5% |
| Hypersensitivity |
1.5% |
| Pain |
1.5% |
| Atrial Fibrillation |
1.1% |
| Dementia |
1.1% |
|
| Hallucination |
12.5% |
| Vomiting |
10.4% |
| Pathological Gambling |
8.3% |
| Restless Legs Syndrome |
8.3% |
| Speech Disorder |
6.3% |
| Weight Increased |
6.3% |
| Drug Ineffective |
4.2% |
| Eosinophilia |
4.2% |
| Proctitis Infectious |
4.2% |
| Sinusitis |
4.2% |
| Somnolence |
4.2% |
| Subileus |
4.2% |
| Suicide Attempt |
4.2% |
| Syncope |
4.2% |
| Toxic Epidermal Necrolysis |
4.2% |
| Adverse Event |
2.1% |
| Angiopathy |
2.1% |
| Cardiovascular Disorder |
2.1% |
| Cerebrovascular Accident |
2.1% |
| Cough |
2.1% |
|
| Interacting |
| Parkinson's Disease |
41.9% |
| Product Used For Unknown Indication |
25.8% |
| Depression |
16.1% |
| Arrhythmia |
6.5% |
| Muscle Spasms |
6.5% |
| Chronic Myeloid Leukaemia |
3.2% |
|
| Serotonin Syndrome |
42.9% |
| Hallucination |
28.6% |
| Application Site Vesicles |
14.3% |
| Rash Generalised |
14.3% |
|
